DK0689426T3 - Terapeutisk middel til behandling af melanomer - Google Patents

Terapeutisk middel til behandling af melanomer

Info

Publication number
DK0689426T3
DK0689426T3 DK94911013T DK94911013T DK0689426T3 DK 0689426 T3 DK0689426 T3 DK 0689426T3 DK 94911013 T DK94911013 T DK 94911013T DK 94911013 T DK94911013 T DK 94911013T DK 0689426 T3 DK0689426 T3 DK 0689426T3
Authority
DK
Denmark
Prior art keywords
melanomas
treatment
therapeutic agent
component
melanoma
Prior art date
Application number
DK94911013T
Other languages
English (en)
Inventor
Lance Elliot Schlipalius
Original Assignee
Cognis Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Australia Pty Ltd filed Critical Cognis Australia Pty Ltd
Application granted granted Critical
Publication of DK0689426T3 publication Critical patent/DK0689426T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK94911013T 1993-03-22 1994-03-22 Terapeutisk middel til behandling af melanomer DK0689426T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL793493 1993-03-22
PCT/AU1994/000141 WO1994021231A1 (en) 1993-03-22 1994-03-22 Therapeutic agent for the treatment of melanomas

Publications (1)

Publication Number Publication Date
DK0689426T3 true DK0689426T3 (da) 2000-10-30

Family

ID=3776793

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94911013T DK0689426T3 (da) 1993-03-22 1994-03-22 Terapeutisk middel til behandling af melanomer

Country Status (10)

Country Link
US (2) US5705180A (da)
EP (1) EP0689426B1 (da)
JP (1) JPH08510994A (da)
AT (1) ATE192921T1 (da)
DE (1) DE69424537T2 (da)
DK (1) DK0689426T3 (da)
ES (1) ES2149264T3 (da)
GR (1) GR3034167T3 (da)
PT (1) PT689426E (da)
WO (1) WO1994021231A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428816B1 (en) * 1994-04-08 2002-08-06 Cognis Australia Pty., Ltd. Carotenoid agent for inhibiting the conversion of epithelial cells to tumors
AUPM493194A0 (en) * 1994-04-08 1994-05-05 Buckmeier, Julie A. Therapeutic agent for inhibiting the conversion of epithelial cells to tumours
DE19609476A1 (de) * 1996-03-11 1997-09-18 Basf Ag Stabile zur parenteralen Verabreichung geeignete Carotinoid-Emulsionen
EP0984915A4 (en) 1997-04-04 2002-11-27 Henkel Corp LUTEINE ESTERS WITH HIGH BIOAVAILABILITY
GB9718636D0 (en) * 1997-09-04 1997-11-05 Smithkline Beecham Plc Novel composition and use
US20070087993A1 (en) 1999-07-29 2007-04-19 Steven Baranowitz Method for transdifferentiation of body tissues
US7070796B1 (en) * 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
US6277417B1 (en) * 2000-04-07 2001-08-21 Triarco Industries, Inc. Method of inhibiting 5α-reductase with astaxanthin
AU2002223013A1 (en) * 2000-12-12 2002-06-24 Debiopharm S.A. Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
US6635293B2 (en) * 2001-10-23 2003-10-21 Kemin Foods, L.C. Finely dispersed carotenoid suspensions for use in foods and a process for their preparation
US6890961B2 (en) * 2002-02-01 2005-05-10 Micelle Products, Inc. Clear micellized formulations of β-carotene and method of treating leukoplakia
US6759436B2 (en) 2002-02-01 2004-07-06 Micelle Products, Inc. Clear micellized formulations of β-carotene and method of treating leukoplakia
US20050004235A1 (en) * 2002-07-29 2005-01-06 Lockwood Samuel Fournier Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7521584B2 (en) * 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7763649B2 (en) * 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US20050026874A1 (en) * 2002-07-29 2005-02-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
US7345091B2 (en) * 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20050049248A1 (en) * 2002-07-29 2005-03-03 Lockwood Samuel Fournier Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7723327B2 (en) * 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US20050009788A1 (en) * 2002-07-29 2005-01-13 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling connexin 43 expression
US20050059659A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid analogs or derivatives for controlling C-reactive protein levels
EP1532108B1 (en) * 2002-07-29 2016-06-29 Cardax Pharma, Inc. Astaxanthin esters for the inhibition and amelioration of disease
US7074990B2 (en) * 2003-06-27 2006-07-11 Agricultural Research Organization, The Volcani Center Carotenoids rich paprika cultivars
JP4526244B2 (ja) 2003-06-30 2010-08-18 ブラザー工業株式会社 インクジェットヘッド及びインクジェットプリンタ並びにインクジェットヘッドの製造方法
CA2564066A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2005105040A2 (en) * 2004-04-26 2005-11-10 Micelle Products, Inc. Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
AU595824B2 (en) * 1985-08-30 1990-04-12 Betatene Limited Narurally-derived carotene/oil composition and the process for the production thereof by direct extraction of carotene from algae
US4680314A (en) * 1985-08-30 1987-07-14 Microbio Resources, Inc. Process for producing a naturally-derived carotene/oil composition by direct extraction from algae
WO1989006977A1 (en) * 1988-02-04 1989-08-10 Board Of Regents, The University Of Texas System Formulation and use of retinoids in treatment of cancer and other diseases
JPH0225418A (ja) * 1988-07-14 1990-01-26 Kyorin Pharmaceut Co Ltd イブジラスト脂肪乳剤およびその製造方法
US5196198A (en) * 1989-06-02 1993-03-23 Abbott Laboratories Parenteral nutrition product
EP0400547A1 (en) * 1989-06-02 1990-12-05 Abbott Laboratories Parenteral nutrition product
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
US5079016A (en) * 1990-05-16 1992-01-07 Kalamazoo Holdings, Inc. Color-stabilized carotenoid pigment compositions and foods colored therewith having increased resistance to oxidative color fading
HUT64837A (en) * 1990-10-01 1994-03-28 Brigham & Womens Hospital Preparatives of beta-carotine and those of vitamine e having ulceration inhibiting effect
DE4031094A1 (de) * 1990-10-02 1992-04-09 Basf Ag Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
US5298246A (en) * 1991-01-09 1994-03-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Stable pharmaceutical composition and method for its production
CH681152A5 (de) * 1991-06-04 1993-01-29 Marigen S.A. Neue biotenside und antitumorale ester und phosphatide mit vitamin-d- und vitamin-e-verbindungen, ihre herstellung und aufarbeitung zu spontan dispergierbaren konzentraten.
ATE212195T1 (de) * 1991-09-06 2002-02-15 Cognis Australia Pty Ltd Carotinoide zusammensetzung
EP0621773B1 (en) * 1992-01-16 1998-11-25 The Board Of Regents, The University Of Texas System Formulation and use of carotenoids in treatment of cancer
JP3547741B2 (ja) * 1992-06-04 2004-07-28 ベータティーン・リミテッド 高シス−β−カロチン組成物

Also Published As

Publication number Publication date
US5705180A (en) 1998-01-06
US5897871A (en) 1999-04-27
DE69424537T2 (de) 2001-11-15
GR3034167T3 (en) 2000-11-30
EP0689426A4 (en) 1998-07-29
PT689426E (pt) 2000-11-30
DE69424537D1 (de) 2000-06-21
ATE192921T1 (de) 2000-06-15
JPH08510994A (ja) 1996-11-19
EP0689426A1 (en) 1996-01-03
EP0689426B1 (en) 2000-05-17
WO1994021231A1 (en) 1994-09-29
ES2149264T3 (es) 2000-11-01

Similar Documents

Publication Publication Date Title
DK0689426T3 (da) Terapeutisk middel til behandling af melanomer
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
YU47993B (sh) Derivati 2,4-diaminohinazolina
NO944430L (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
GR3024181T3 (en) N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors.
GB9514473D0 (en) Chemical compounds
DK0993831T3 (da) Forbindelser og præparater til tilförsel af aktive stoffer
DK0480950T3 (da) Kombinationsterapi til profylakse for og/eller behandling af godartet prostatahypertrofi
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
GR3032161T3 (en) Amido siladiyl bridged catalyst components, methods of making and using
ES2114931T3 (es) Nuevos esteres esteroidales.
DK0514452T3 (da) Anvendelse af insulin-sensibiliserende midler til behandling af hypertension
ATE193647T1 (de) Di- und trivalente kleine moleküle als selektininhibitoren
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
EP0646007A1 (en) NEW DELTA-17 AND DELTA-20 UNSATURATED AND SATURATED 17 - g (b) -SUBSTITUTED-4-AZA-5-g (a) -ANDROSTAN-3-ON COMPOUNDS AS INHIBITORS OF 5-ALPHA REDUCTASE.
ATE163679T1 (de) Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor
DK0934065T3 (da) Hidtil ukendte cruptophycinderivater som antieoplastiske midler
GR3036782T3 (en) Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding.
ID21545A (id) Turunan biphenil yang tersubstitusi dengan radikal aromatik atau heteroaromatik, serta komposisi farmasi dan kosmetik yang mengandungnya
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
IT1270993B (it) Derivati chinzolilamminici attivi come alfa-antagonisti
GB2380939B (en) Treatment or prevention of auto-immune diseases
DK0684816T3 (da) 5-HT2-receptorantagonister til behandling af venöse tilstande
ITMI921551A1 (it) Glutatione come agente chemioprotettivo
DK0588796T3 (da) Sampanginderivater til anvendelse som antifungiske og antimykobakterielle midler